Marco Radi

3.1k total citations
97 papers, 2.5k citations indexed

About

Marco Radi is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Marco Radi has authored 97 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Organic Chemistry, 39 papers in Molecular Biology and 22 papers in Infectious Diseases. Recurrent topics in Marco Radi's work include Quinazolinone synthesis and applications (17 papers), HIV/AIDS drug development and treatment (16 papers) and HIV Research and Treatment (16 papers). Marco Radi is often cited by papers focused on Quinazolinone synthesis and applications (17 papers), HIV/AIDS drug development and treatment (16 papers) and HIV Research and Treatment (16 papers). Marco Radi collaborates with scholars based in Italy, United States and United Kingdom. Marco Radi's co-authors include Maurizio Botta, Silvia Schenone, Francesca Musumeci, Chiara Brullo, Giovanni Maga, Fabrizio Manetti, Daniele Castagnolo, Beatrice Bechi, Emmanuele Crespan and Rita Meleddu and has published in prestigious journals such as Chemical Reviews, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Marco Radi

92 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Radi Italy	29	1.4k	981	349	210	201	97	2.5k
Emmanuele Crespan Italy	26	963 0.7×	1.1k 1.1×	328 0.9×	211 1.0×	204 1.0×	95	2.2k
Cristina Tintori Italy	27	861 0.6×	724 0.7×	300 0.9×	234 1.1×	136 0.7×	52	1.8k
Daniel A. Harki United States	28	422 0.3×	1.6k 1.6×	371 1.1×	239 1.1×	280 1.4×	77	2.6k
Jeremy Green United States	26	828 0.6×	1.4k 1.4×	290 0.8×	206 1.0×	298 1.5×	51	2.4k
Zhenyu Li China	27	744 0.5×	1.3k 1.3×	419 1.2×	308 1.5×	430 2.1×	111	2.6k
Maria Bretner Poland	25	630 0.5×	1.1k 1.1×	270 0.8×	72 0.3×	196 1.0×	82	1.9k
Shridhar Bhat United States	21	403 0.3×	1.5k 1.6×	333 1.0×	234 1.1×	331 1.6×	37	2.6k
V. L. Narayanan United States	24	890 0.6×	1.0k 1.0×	406 1.2×	223 1.1×	411 2.0×	68	2.2k
Peng Zhan China	23	799 0.6×	766 0.8×	495 1.4×	345 1.6×	179 0.9×	87	2.1k
Nouri Neamati United States	26	635 0.5×	1.1k 1.1×	276 0.8×	269 1.3×	923 4.6×	50	2.5k

Countries citing papers authored by Marco Radi

Since Specialization

Citations

This map shows the geographic impact of Marco Radi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Radi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Radi more than expected).

Fields of papers citing papers by Marco Radi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Radi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Radi. The network helps show where Marco Radi may publish in the future.

Co-authorship network of co-authors of Marco Radi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Radi. A scholar is included among the top collaborators of Marco Radi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Radi. Marco Radi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Radi, Marco, et al.. (2025). Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: Myth or real opportunity?. Antiviral Research. 235. 106100–106100. 3 indexed citations

Incerti, Matteo, et al.. (2024). A Microwave‐Assisted One‐Pot Three‐Step Metal‐Free [4+2] Annulation for the Sustainable Synthesis of Highly Substituted 1,2,4‐Triazines. European Journal of Organic Chemistry. 27(19). 1 indexed citations

Crespan, Emmanuele, et al.. (2024). Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families. Antiviral Research. 231. 106003–106003. 4 indexed citations

Giorgio, Carmine, et al.. (2024). Benzofuran‐2‐Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20‐Induced Chemotaxis and Colon Cancer Growth. ChemMedChem. 19(20). e202400389–e202400389.

Vicenti, Ilaria, Elisabetta Groaz, Jef Rozenski, et al.. (2023). Nucleoside Derivatives of 2,6‐Diaminopurine Antivirals: Base‐Modified Nucleosides with Broad‐Spectrum Antimicrobial Properties. ChemMedChem. 18(16). e202300200–e202300200. 2 indexed citations

Leech, Matthew C., Darren L. Poole, J. S. Mason, et al.. (2023). eHydrogenation: Hydrogen‐free Electrochemical Hydrogenation. Angewandte Chemie International Edition. 62(38). e202309563–e202309563. 36 indexed citations

Leech, Matthew C., Darren L. Poole, J. S. Mason, et al.. (2023). eHydrogenation: Hydrogen‐free Electrochemical Hydrogenation. Angewandte Chemie. 135(38).

Lupo, Maria Giovanna, Ilaria Rossi, Antonietta Vilella, et al.. (2023). Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability. European Journal of Medicinal Chemistry. 265. 116063–116063. 5 indexed citations

Giorgio, Carmine, Elisabetta Barocelli, Vigilio Ballabeni, et al.. (2022). Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases. European Journal of Medicinal Chemistry. 243. 114703–114703. 15 indexed citations

10.

Vicenti, Ilaria, Adele Boccuto, Marta De Angelis, et al.. (2021). System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. European Journal of Medicinal Chemistry. 224. 113683–113683. 15 indexed citations

11.

Zamperini, Claudio, Elena Dreassi, Gianluca Vignaroli, et al.. (2014). CYP-dependent Metabolism of Antitumor Pyrazolo[3,4-d]pyrimidine Derivatives Is Characterized by an Oxidative Dechlorination Reaction. Drug Metabolism and Pharmacokinetics. 29(6). 433–440. 6 indexed citations

12.

Radi, Marco, Silvia Schenone, & Maurizio Botta. (2013). Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders. Current Pharmaceutical Biotechnology. 14(5). 477–487. 8 indexed citations

13.

Mori, Mattia, Cristina Tintori, Marco Radi, et al.. (2013). A Combination Strategy to Inhibit Pim‐1: Synergism between Noncompetitive and ATP‐Competitive Inhibitors. ChemMedChem. 8(3). 484–496. 15 indexed citations

14.

Radi, Marco, Federico Falchi, Anna Garbelli, et al.. (2012). Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 2094–2098. 72 indexed citations

15.

Radi, Marco, Lasse Evensen, Elena Dreassi, et al.. (2012). A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation. Bioorganic & Medicinal Chemistry Letters. 22(17). 5579–5583. 19 indexed citations

16.

Garbelli, Anna, Marco Radi, Federico Falchi, et al.. (2011). Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication. Current Medicinal Chemistry. 18(20). 3015–3027. 48 indexed citations

17.

Radi, Marco, Silvia Schenone, & Maurizio Botta. (2009). Recent highlights in the synthesis of highly functionalized pyrimidines. Organic & Biomolecular Chemistry. 7(14). 2841–2841. 68 indexed citations

18.

Castagnolo, Daniele, Alessandro De Logu, Marco Radi, et al.. (2008). Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 16(18). 8587–8591. 124 indexed citations

19.

Radi, Marco, Chiara Falciani, Elena Petricci, et al.. (2007). A Multidisciplinary Approach for the Identification of Novel HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors: S‐DABOCs and DAVPs. ChemMedChem. 3(4). 573–593. 32 indexed citations

20.

Radi, Marco, Emmanuele Crespan, Giorgia Botta, et al.. (2007). Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Bioorganic & Medicinal Chemistry Letters. 18(3). 1207–1211. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact